| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b99e2c723498fb91a5f3957b9560a17a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 |
| filingDate |
2018-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0d035c1859182456aa0e7293a9bbb7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_869da1c1901ed040ca90d18235235a88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d136f21456cb6230f139b00dae27590e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7313f52f151a3ded087f766d6798c87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d8261f908ed743078ac8c4bc75a509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a4324dbcfa117075f44b17635e7b7c2 |
| publicationDate |
2020-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3606563-A1 |
| titleOfInvention |
Use of a liposome encapsulating a sugar compound in cest imaging |
| abstract |
The invention provides agents for use in methods of saturation transfer mediated imaging (such as CEST imaging) in a subject, which agents comprise a liposome encapsulating a suitable sugar compound. The disclosure provides novel liposome formulations, which can be used for diagnostic and theranostic purposes. The liposomes can be shielded and\or targeted to a sugar uptake site such as a tumour. The invention has particular utility in modulating the glycaemic response to the encapsulated sugar compound in the subject. |
| priorityDate |
2017-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |